Zepbound is available in both prefilled pens and vials, with the pens offering a wider range of doses and the vials requiring syringe administration. If deemed appropriate, the healthcare ...

Doctors argue that both drugs should remain available because some patients in fact do better on Wegovy than on Zepbound, losing more weight or experiencing fewer or milder side effects.

Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...

CVS’s drug-benefits unit, known as Caremark, earlier this month negotiated a deal to make Novo’s Wegovy more widely available to its customers — knocking Eli Lilly & Co.’s Zepbound off its ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than ... As more options become available, patients and providers can better tailor treatment to individual needs and preferences.

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

The 2.5mg vial is available at $399 per month. Lilly claims the single-dose versions cost at least 50% less than the list price of other incretin medicines for obesity. "Offering Zepbound single ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...